logo
Hepatitis: Infections that drive liver disease

Hepatitis: Infections that drive liver disease

The Star2 days ago
The liver is a vital organ that plays a central role in key bodily functions, including metabolism, immunity, digestion and detoxification.
When the liver becomes inflamed or swollen – a condition known as hepatitis – these functions can be disrupted, potentially leading to health complications ranging from mild discomfort to severe liver damage.
The most common cause of hepatitis is viral infection.
It is classified based on the specific virus involved, i.e. hepatitis A, B, C, D or E.
Hepatitis A and E are typically transmitted through contaminated food or water, while hepatitis B, C and D are more commonly spread through contact with infected blood or bodily fluids.
Aside from viral infections, other causes of hepatitis include excessive alcohol consumption, exposure to toxins, or certain autoimmune diseases.
Several groups face a higher risk of contracting hepatitis, such as healthcare workers, people who use injectable drugs, individuals with multiple sexual partners, and babies born to mothers who are infected with hepatitis.
Hepatitis can be classified as either acute or chronic.
Acute hepatitis refers to short-term inflammation of the liver, which may resolve on its own without long-term effects.
However, in some cases, it can progress into chronic hepatitis.
This condition lasts for more than six months and may lead to serious complications, such as cirrhosis, liver failure or liver cancer.
In many instances, people with hepatitis do not show any noticeable symptoms during the early stages of infection.
As the disease progresses, however, several common symptoms may appear, including: Yellowing of the skin and eyes (jaundice)
Dark-coloured urine
Fatigue
Loss of appetite
Nausea
Vomiting, or
Abdominal pain.
In Malaysia
Hepatitis infections remain a significant public health challenge in Malaysia.
The two most common types are hepatitis B and C, both of which contribute heavily to the national burden of liver-related diseases.
Several factors drive the continued spread of these infections, including limited public awareness, restricted access to healthcare in rural areas, and high-risk behaviours.
According to Health Ministry statistics, between 2013 and 2023, there were 49,992 reported cases of hepatitis B and 34,573 cases of hepatitis C.
In 2016 at the 69th World Health Assembly, Malaysia pledged its commitment to eliminate viral hepatitis as a public health threat by 2030.
In line with this goal, the Health Ministry has adopted a multisectoral approach in addressing hepatitis B and C.
Collaboration among government agencies, the private sector and non-governmental organisations includes screening efforts, provision of treatment and immunisation services, as well as advocacy and public education initiatives.
Public health strategies in the country focus primarily on hepatitis B and C because these types are the main causes of chronic liver disease and liver cancer.
In contrast, hepatitis A and E are usually self-limiting and do not require long term treatment, while hepatitis D is rare and only occurs alongside hepatitis B infection.
As hepatitis B and C pose a greater burden on the healthcare system, they are prioritised in screening, treatment and prevention efforts.
Prevention and treatment
One of the key strategies to prevent the spread of hepatitis is immunisation.
In Malaysia, vaccines are available for hepatitis A and hepatitis B.
Specifically, the hepatitis B vaccine is included in the National Immunisation Programme (NIP) and is routinely administered to newborns.
Furthermore, for pregnant mothers who are diagnosed with hepatitis B, antiviral prophylaxis is given to reduce the risk of transmitting the virus to the unborn baby.
Apart from immunisation, routine screening for hepatitis is equally important.
In particular, it should be prioritised among high risk groups, blood donors and foreign workers.
Early detection not only allows for prompt initiation of treatment, but also helps reduce transmission within the community.
While prevention remains a crucial aspect in combating hepatitis, effective treatment is equally important in managing the disease.
Treatment for viral hepatitis plays a vital role in improving long-term survival.
However, not all individuals with hepatitis require treatment.
In certain cases, the immune system is capable of limiting the virus from replicating without medical intervention.
Therefore, the decision to begin treatment depends on several factors, including liver function, viral load and other co-existing health conditions.
For chronic hepatitis B, treatment involves the use of antiviral medications that work by inhibiting viral replication.
These include nucleoside analogues such as entecavir, and nucleotide analogues such as tenofovir.
These oral medications do not cure hepatitis B, but they help to reduce the risk of serious complications and improve long-term survival.
Most patients need to take these medications for life.
Another treatment option for hepatitis B is peginterferon alpha injection, which is an immunomodulator that boosts immunity against infection.
In Malaysia, this treatment is usually reserved for patients who do not respond to, or cannot tolerate, oral antiviral medications.
It is not recommended for pregnant or breastfeeding mothers.
On the other hand, hepatitis C is treated with direct-acting antiviral medicines such as sofosbuvir, daclatasvir, ribavirin and ravidasvir.
These medications have been shown to cure more than 95% of hepatitis C cases, with shorter treatment duration and fewer side effects.
They act by disrupting the virus replication cycle.
Before starting this treatment, healthcare providers will explain how to take the medication properly, the importance of not sharing it with others, and the need to avoid any medication that might interact with the treatment.
This is to ensure the success of the hepatitis C treatment.
Although antiviral medications for hepatitis B and hepatitis C are generally safe and well tolerated, some patients may experience side effects such as headache, nausea, fatigue or skin rashes.
If any of these symptoms occur or if there are concerns about starting treatment, it is important to consult a doctor for further advice.
Advice for patients
In addition to taking prescribed medications, hepatitis patients are advised to maintain a healthy lifestyle.
This includes eating a well-balanced diet, engaging in regular physical activity, getting tested for HIV (human immunodeficiency virus), limiting alcohol intake, and getting vaccinated against hepatitis B if they have hepatitis C.
Similarly, those with hepatitis B are advised to get tested for hepatitis C.
Patients should also consult their healthcare providers before starting any new medications, supplements or traditional products.
Moreover, hepatitis patients should avoid behaviours that can lead to transmission of the virus.
These include sharing personal items such as toothbrushes, razors or nail clippers, donating blood, and having unprotected sexual intercourse.
In conclusion, a better understanding of the many aspects of hepatitis empowers individuals and communities to take proactive steps to prevent infection, seek timely diagnosis and access appropriate treatment.
As part of global efforts to raise awareness, World Hepatitis Day is observed annually on July 28.
This year's theme 'Let's break it down' underscores the need to overcome barriers in understanding hepatitis so that it can be effectively managed, treated, and ultimately, eliminated.
For any inquiries about medicines, please call the National Pharmacy Call Centre (NPCC) at the toll-free number 1-800-88-6722 during weekdays from 8am to 5pm, except on public holidays.
Umi Kalthum Mohd Isa is a pharmacist at Hospital Sultan Idris Shah in Serdang, Selangor. This article is courtesy of the Health Ministry's Pharmacy Practice and Development Division. For more information, email starhealth@thestar.com.my. The information provided is for educational and communication purposes only, and should not be considered as medical advice. The Star does not give any warranty on accuracy, completeness, functionality, usefulness or other assurances as to the content appearing in this article. The Star disclaims all responsibility for any losses, damage to property or personal injury suffered directly or indirectly from reliance on such information.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Health ministry, Google explore AI to address challenges
Health ministry, Google explore AI to address challenges

Free Malaysia Today

time6 hours ago

  • Free Malaysia Today

Health ministry, Google explore AI to address challenges

Health minister Dzulkefly Ahmad said Malaysia is committed to driving regional cooperation in health data governance, ethical use of AI, and cross-border digital capacity building. (Bernama pic) PETALING JAYA : The health ministry and Google are exploring a strategic partnership to use artificial intelligence (AI) to address the country's key health challenges. Health minister Dzulkefly Ahmad said the move is a 'major step' towards making Malaysia the leader in AI-based digital health in the region. He said that as the chair of Asean this year, Malaysia is committed to driving regional cooperation in health data governance, ethical use of AI, and cross-border digital capacity building. Dzulkefly said 156 health clinics have been equipped with a cloud-based content management system allowing 70% of patients to be treated in less than 30 minutes. This was part of the AI-based digital reforms that his ministry is implementing. He also said the first phase of the Electronic Medical Record system has been completed, involving five million prescriptions, 20 million vaccination records, and one million dental records. In addition, the MySejahtera app has now been developed into a preventive health gateway and a national digital gateway.

‘AI used to aid dengue efforts'
‘AI used to aid dengue efforts'

The Star

time9 hours ago

  • The Star

‘AI used to aid dengue efforts'

THE Health Ministry is utilising artificial intelligence (AI) to predict future dengue hotspots, with the aim of enhancing targeted interventions against the disease. Health Minister Datuk Seri Dr Dzulkefly Ahmad said this initiative is part of the government's broader strategy to combat dengue. 'We are integrating predictive AI tools to map potential dengue hotspots before outbreaks occur. This approach allows us to implement more targeted and effective interventions,' he said. A key strategy in the government's long-term dengue response is the introduction of Wolbachia-infected mosquitoes, which have been deployed across 45 localities in Malaysia. Dr Dzulkefly said that the method has shown strong results in suppressing the Aedes aegypti mosquito population, the main vector for dengue. 'In some areas, we've seen a reduction in cases by up to 45%, and in others, such as in Penang, the results are even more remarkable with a 100% reduction in cases,' he said.

‘Women don't prioritise their own health'
‘Women don't prioritise their own health'

The Star

time10 hours ago

  • The Star

‘Women don't prioritise their own health'

PETALING JAYA: Despite human papillomavirus (HPV) being widespread in Malaysia, many women remain unaware of the serious health risks it poses. According to the World Health Organisation (WHO), HPV is a common sexually transmitted infection, with nearly all sexually active individuals contracting it at some point, often without symptoms. High-risk HPV can lead to various cancers, including cervical, anal, oropharyngeal, penile, vaginal and vulvar cancers. Health Minister Datuk Seri Dr Dzulkefly Ahmad recently revealed that over 10,500 women in Malaysia tested positive for HPV through cervical cancer screenings over the past five years, and 65% of women have not undergone any screenings in the past three years. Nurse Venmathi Pradeep Kumar, 24, from Ampang, said women often put others' health before their own. 'I think this is where perhaps the workplace can fund or organise health screenings for female employees. 'There can also be more culturally sensitive and inclusive health promotions or educational programmes, either at workplaces or schools,' she said. Librarian Erin Carina Jauti, 24, from Kuala Lumpur, said many women deprioritise health check-ups, including HPV screening. 'It's not because they don't care, they may not have the means either financially or physically. 'Like if you have to choose between seeing a doctor or paying rent or other commitments, which one would you choose? 'There are also rural women, who may find topics like period or cervical examination shameful,' she said. She called for more open conversations on HPV to break the stigma. She also suggested outsourcing screenings to general clinics at subsidised rates for wider access. Assistant manager Ang Xiwen, 32, from Kuala Lumpur, noted that the lack of urgency stems from poor awareness. 'I think the awareness itself among women is not strong enough, and that's why I don't feel the need to pay for screening. 'But I would appreciate it if the company provides free screenings for their female employees,' she said. Bank employee Alia A., 27, from Kuala Lumpur, admitted she was unaware of HPV-related risks. She urged the Health Ministry to intensify awareness efforts and make screenings part of employee medical benefits. 'I will gladly go to any GP to get a mandatory screening,' she said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store